Indication
Lowering IOP in open-angle glaucoma or ocular hypertension, for those intolerant or insufficiently responsive to other IOP lowering medications
Mechanism of Action
Travoprost free acid, a selective FP prostanoid receptor agonist, is believed to reduce IOP by increasing uveoscleral outflow.
Available Quantities
2.5 ml, 5 ml
Dosage/Instructions
1 drop in the affected eye(s) once daily in the evening
Pregnancy & Nursing
Embryo-fetal lethality shown in rats with low dose subcutaneous injections. Use only if the potential benefit justifies the potential risk to the fetus.
Pediatric Use
≥16 years
Contraindications, side effects, etc.
Contraindications: Hypersensitivity to dorzolamide. Warnings: Use with caution in patients with renal impairment or a history of kidney stones. Common Side Effects: Temporary blurred vision, temporary burning/stinging/itching/redness of the eye, watery eyes, dry eyes, sensitivity of eyes to light, bitter taste, or headache
